ASLAN to develop next-gen DHODH inhibitor in autoimmune conditions

ASLAN Pharmaceuticals, clinical-stage immunology focused biopharmaceutical company developing innovative treatments to t...

October 16, 2020 | Friday | News
Prestige Biopharma receives ODD to its Pancreatic Cancer drug

Prestige BioPharma Ltd. on 13 Oct 2020 announced that the European Medicines Agency (EMA) Orphan Drug Commission (C...

October 14, 2020 | Wednesday | News
Antengene partners with WuXi Biologics for innovative oncology medicines

Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...

October 14, 2020 | Wednesday | News
Eisai collaborates with University of Tokyo for protein degradation drug discovery

The University of Tokyo and Eisai Co., Ltd. have announced a collaboration aiming for the development and drug discovery...

October 13, 2020 | Tuesday | News
Antengene establishes new drug discovery centre in Shanghai

Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...

October 13, 2020 | Tuesday | News
Marinomed Biotech develops novel drug for the treatment of autoimmune gastritis

Marinomed Biotech AG, a Vienna-based biopharmaceutical company, develops groundbreaking treatment for autoimmune gastrit...

October 9, 2020 | Friday | News
Standigm releases AI-based target identification platform for drug discovery

South Korea based Standigm Inc., an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, ...

October 1, 2020 | Thursday | News
Standigm partners with Excelra to enhance AI-driven drug discovery process

Excelra, a global data science and data analytics company headquartered in India, has announced its collaboration with S...

September 15, 2020 | Tuesday | News
Eisai takes Counter-Measures to tackle COVID-19 spread in Africa

Eisai Co., Ltd. announced on 10 June 2020 that it has committed the equivalent of 1 million USD in aid towards various a...

June 10, 2020 | Wednesday | News
India's Sun Pharma to start nafamostat mesylate trial for COVID-19

India-based Sun Pharmaceutical Industries Ltd (Sun Pharma) has received Indian regulatory approval to start clinical tri...

June 3, 2020 | Wednesday | Analysis
Roche’s Tecentriq approved for extensive-stage small cell lung cancer

Roche, a global leading provider of pharmaceuticals and cancer treatments, today announced that the Health Sciences Auth...

May 19, 2020 | Tuesday | News
Exyte and Univercells combine forces for rapid deployment of COVID-19 vaccine

Exyte, world-renowned for the design and construction of high tech facilities, and Univercells Technologies, a prov...

May 14, 2020 | Thursday | News
Astellas, Insilico Medicine bank on AI for drug discovery

Hong Kong based Insilico Medicine has announced that it has entered into a research collaboration agreement with Ja...

May 4, 2020 | Monday | News
Senhwa Biosciences, NIH to co-develop COVID-19 drug

Taiwan headquartered Senhwa Biosciences Inc announced that it has partnered with the US National Institutes of Health (N...

April 27, 2020 | Monday | News
Esperion & Otsuka to develop treatment for hypercholesterolemia

US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...

April 23, 2020 | Thursday | News
Insilico collaborates with BI for discovering therapeutic targets

Hong Kong headquartered Insilico Medicine has announced that it has entered into a research collaboration with Boehringe...

April 23, 2020 | Thursday | News
Combined treatment from existing drugs might combat COVID-19

There is no specific drug which can fight against COVID-19 yet. Developing a specific drug is quite tough. It is no...

April 17, 2020 | Friday | News
Fujifilm accelerates favipiravir production for COVID-19 treatment

Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...

April 16, 2020 | Thursday | News